drugset / Trial / NCT00902304
Valsartan Intensified Primary Care Reduction of Blood Pressure Study
Phase 4
Completed
2337 enrolled
Novartis Pharmaceuticals
Baker Heart and Diabetes Institute · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will assess the efficacy of an intensive blood pressure management strategy compared to usual care in a primary care (general practice) setting.
Timeline
- Start
- 2009-07
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 10 mg | Oral |
| Subject | Hydrochlorothiazide | Unknown | 25 mg | Oral |
| Subject | Valsartan | Small molecule | 160 mg | Oral |
| Subject | Valsartan | Small molecule | 320 mg | Oral |